Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Remimazolam sedation in ICU patients on mechanical ventilation

Official title: Effect of Remimazolam Sedation on Outcomes of Mechanically Ventilated Patients in the ICU

Run by Southeast University, China · NCT07596589 · Data updated 2026-11-12

This study tests whether using remimazolam for sedation helps mechanically ventilated ICU patients recover better compared to another sedative.

More Sedation trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorSoutheast University, China
Academic / other
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedApril 1, 2025
Main results expectedJanuary 31, 2027
Study endsJanuary 31, 2027
Registry record updatedMay 19, 2026
Trial IDNCT07596589 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) who are endotracheally intubated and mechanically ventilated for 24–96 hours and require continued ventilation and sedation for at least 24 hours, with consent provided by family.

Probably not a fit

Patients who do not respond to remimazolam or who meet exclusion criteria may not experience a benefit and could experience sedation-related adverse events.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective, randomized controlled pilot study in ICU patients who require mechanical ventilation and sedation. Participants will be assigned to receive remimazolam or an alternative sedative (such as propofol) to reach a target RASS between 0 and -3. The goal is to observe effects on outcomes relevant to ventilation and recovery, with safety and tolerability monitored throughout the course of sedation and withdrawal. The trial aims to generate preliminary data to inform larger studies on sedation strategies in this population.

Why it matters

Potential benefit: If successful, remimazolam could offer effective sedation with favorable recovery and safety profiles for mechanically ventilated ICU patients.

How similar studies have gone: Previous sedative comparisons in ICU settings have shown variability; as a pilot, this study explores a relatively novel use of remimazolam in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years;
* Endotracheal intubation and mechanical ventilation for 24-96 hours before enrollment Expected need for continued invasive ventilation and sedation for at least 24 hours;
* Target sedation depth on the Richmond Agitation-Sedation Scale (RASS) between 0 and -3;
* Informed consent obtained from the patient's family

Exclusion Criteria:

* Body mass index (BMI) \> 30 kg/m²
* Severe central nervous system disease (e.g., acute stroke, uncontrolled seizures, or severe dementia) or any other condition that precludes RASS assessment
* Mean arterial pressure (MAP) \< 55 mmHg despite intravenous fluid resuscitation and vasopressors
* Heart rate \< 50 beats per minute, or second-degree or third-degree atrioventricular block in the absence of a pacemaker
* Acute myocardial infarction or severe heart failure (New York Heart Association \[NYHA\] class IV)
* Left ventricular ejection fraction \< 30%
* Any contraindication or allergy to benzodiazepines
* Substance dependence, alcohol abuse, or psychiatric/psychological disorders. Alcohol abuse was defined as regular consumption of \> 14 drinks per week (1 drink = 150 mL wine, 360 mL beer, or 45 mL liquor)
* Acute hepatitis or severe hepatic dysfunction (Child-Pugh class C)
* Chronic kidney disease with a glomerular filtration rate (GFR) \< 60 mL/min/1.73 m²
* Neuromuscular disease
* Patients on extracorporeal membrane oxygenation (ECMO)
* Pregnancy or breastfeeding

Where it's running

  • Zhongda Hospital
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.